Bain said its decision to buy Mitsubishi Tanabe is due to the “strong growth potential” of Japan’s healthcare industry.

U.S. private equity firm Bain Capital has bought Mitsubishi Tanabe Pharma in a deal worth 510 billion yen ($3.4 billion), ...

Japan's Mitsubishi Chemical said on Friday it will sell pharmaceutical subsidiary Tanabe Mitsubishi Pharma to U.S. private ...

Mitsubishi UFJ Financial Group's dividend yield and buyback program boost value. Learn why MUFG stock is a solid investment ...

Bain Capital is nearing a deal to buy Mitsubishi Chemical Group Corp.’s pharmaceutical unit, people familiar with the matter ...

Japan's Mitsubishi Corp posted on Thursday a 19% increase in nine-month net profit to December to 827.4 billion yen ($5.43 ...

The investment firm is acquiring Mitsubishi Tanabe Pharma in a deal valued at $3.3 billion. Elsewhere, Bausch + Lomb hasn’t ...

Mitsubishi Corp on Monday said it is reviewing how to proceed with its offshore wind projects in Japan given a "significantly ...

Mitsubishi Corp has recorded an impairment charge of Y52.2bn ($342.4m) on its offshore wind projects in Japan.

Mitsubishi Motors is facing a tough financial year, with the company slashing its net profit forecast by a staggering 76%.

Mitsubishi Motors Corp. (MMC) is planning to invest P7 billion in the Philippines in the next five years, Malacañang ...

Following rumblings of a private equity bidding war late last year, Bain Capital has emer | Bain Capital is laying out 510 ...